Is there really such a thing as 'chemo brain?'

 

Q: Is there really such a thing as "chemo brain" that creates difficulty with concentration and makes me more forgetful? 

A: Chemotherapy can negatively affect your cognitive functioning. How it does this is still unclear. Other factors, such as anemia (low red blood count), aging, or depression may contribute to your difficulties. Problems with memory and concentration can stop after treatment ends or continue as long-term side effects.

Research is exploring how to prevent or counteract "chemo brain," but no scientific solution has been found as yet. If you're having cognition problems, try reducing distractions when you need to concentrate, use a daily planner to stay organized, write down things you want to remember, and reduce stress with regular exercise and ample sleep.
--Bernice Crook, RN, OCN

More severe confusion has several treatable causes.

Latest Cancer News
Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Anastrozole

March 10, 2010 — Researchers affiliated with the TransATAC Study have reported that the Oncotype DX® test predicts the risk of distant cancer recurrence in postmenopausal women with early, hormone receptor-positive breast cancer with both node-negative and node-positive disease treated with tamoxifen (Nolvadex®) or anastrozole (Arimidex®). These results were published early online in the Journal of Clinical Oncology on March 8, 2010.

Recent Results of High-dose Proleukin® for Metastatic Renal Cell Carcinoma Reported

March 10, 2010 — Researchers involved in a U.S. multicenter trial (Cytokine Working Group) have reported that high-dose Proleukin® (aldesleukin, interleukin-2, IL-2) results in a higher response rate in patients with metastatic renal cell carcinoma (MRCC) than historically reported. The details of this study were presented at the 2010 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, March 5-7, in San Francisco.

Cystoscopy Remains Best Method for Surveillance of Patients with Bladder Cancer

March 10, 2010 — Researchers from the M. D. Anderson Cancer Center have reported that cystoscopy alone remains the most cost-effective method of detecting recurrent superficial bladder cancer. The details of this study were presented at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium March 5-7 in San Francisco.

Select news items provided by Reuters Health